Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
about
Target therapy in metastatic pheochromocytoma: current perspectives and controversiesConnecting molecular pathways to hereditary cancer risk syndromesTargeting heat shock protein 90 for the treatment of malignant pheochromocytomaCytocidal activities of topoisomerase 1 inhibitors and 5-azacytidine against pheochromocytoma/paraganglioma cells in primary human tumor cultures and mouse cell linesCurrent views on cell metabolism in SDHx-related pheochromocytoma and paragangliomaMolecular markers of paragangliomas/pheochromocytomasParagangliomas/Pheochromocytomas: clinically oriented genetic testingCombination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude micePheochromocytoma and paraganglioma in cyanotic congenital heart disease.Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling PathwaysUpdated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma.Inhibitory Effect of the Noncamptothecin Topoisomerase I Inhibitor LMP-400 on Female Mice Models and Human Pheochromocytoma CellsCombined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice.Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations.Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomasAnti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cellsRole of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas.Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas.Successful treatment of paraganglioma with sorafenib: a case report and brief review of the literature.Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.Malignancy in Pheochromocytoma or Paraganglioma: Integrative Analysis of 176 Cases in TCGA.Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine
P2860
Q28087343-B135D690-3273-4E54-A824-5B4E6E9E1B9DQ28291516-C5BE1C7C-DD08-476E-A8DA-AA3DF3C173BEQ28486170-F6EF6EE9-58DE-4818-91BC-3908A9FCDBECQ28539650-9C35181C-CD6C-416F-AFF6-97BC2A2A507FQ33590969-AC69CC29-3913-423A-BFE1-9568E1053216Q33649025-A1A0AC53-CB8C-46ED-BFAD-160EEBFF2D34Q33679204-7766EC7B-C41C-4DC0-B99E-685A433B7006Q33765524-4CE26E8F-F9BF-46A8-8810-E3E13996F277Q35441891-E0EAE16F-1804-4317-B2F9-655E2E1B9828Q35860831-9612CE3D-0E8F-4A45-A818-598587A0E016Q36125143-10A5371C-B37B-4EF6-9575-3319DAC4CAAEQ36164329-E94FC344-E77A-430C-9E7B-472915DA405EQ36542866-A9DA5EC8-1B34-4976-AEB2-DEDEE35D5D3EQ36594111-DB13F078-AF25-4262-A792-24B6AFCCA122Q36804496-1606376A-B57E-4037-9D25-6BEF9D806709Q36948906-496A217E-87D4-40F4-8938-70B900151709Q37202015-5A3C741A-261E-4CCA-8B55-A0316566E60BQ37470890-15E84E50-564F-4ABE-B1AB-344CA5F1E5DCQ37541311-7851E52D-1460-4DD8-927E-202EEF8166A8Q38162840-B587F471-3743-4F61-8733-A554D5CFACC5Q38831451-433379FF-C8DE-49CE-B5EF-EE938ADF5B17Q39328101-63EA8D61-7948-450D-B8F3-9B79513EC28BQ52777897-581AAFB6-BBBE-4739-BE2F-CE365CBBB740Q58700167-84A05315-FF89-45CC-B844-88A39B5029DD
P2860
Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Signaling pathways in pheochro ...... rospects for future therapies.
@en
Signaling pathways in pheochro ...... rospects for future therapies.
@nl
type
label
Signaling pathways in pheochro ...... rospects for future therapies.
@en
Signaling pathways in pheochro ...... rospects for future therapies.
@nl
prefLabel
Signaling pathways in pheochro ...... rospects for future therapies.
@en
Signaling pathways in pheochro ...... rospects for future therapies.
@nl
P2860
P1433
P1476
Signaling pathways in pheochro ...... rospects for future therapies.
@en
P2093
Ashley B Grossman
Svenja Nölting
P2860
P2888
P356
10.1007/S12022-012-9199-6
P577
2012-03-01T00:00:00Z